Group items matching

in title, tags, annotations or url

The name coronavirus is derived from the Latin word corona meaning crown, Coronaviruses are a large family of viruses that infects the lungs

Hundreds of children in England are set to benefit from a treatment for cystic fibrosis - Kaftrio, after the UK's Medicines and Healthcare products Regulatory Agency (MHRA) confirmed an extension to its licence. With the licence extension, more than 1,300 children in England with cystic fibrosis, aged six to 11, are newly eligible for this treatment, which improves lung function and improves overall quality of life of patients. Earlier, Kaftrio was only licensed for those aged 12 and above. British patients were the first in Europe to benefit from Kaftrio, when NHS England secured a landmark deal in June 2020. NHS chief executive Amanda Pritchard said: "Since NHS staff delivered one of the fastest rollouts of Kaftrio in the world just over a year ago, the lives of thousands of patients with cystic fibrosis have been transformed. "Innovative treatments like Kaftrio are life-changing for patients and their families, and that is why the NHS has done all it can since we secured the deal for Kaftrio to ensure patients benefit as soon as possible.

Acupressure Spine Roller : (Magnetic Deluxe) This device is useful for back pain, back discomfort, spine trouble and muscle fatigue, etc. Tone up of spinal nerves and revitalizes total body, removes stiffness. It can also be used as a body massager. Office employees may take use daily for 5 minutes to avoid unnecessary backache. Its deluxe shape specially designed for firm grip and full pressure.

Thanks for sharing. Actually, I often suffer from back pain. I tried so many treatments, but nothing helps. And of course, I'm scared to take many meds, because of all those side effects stated at the https://www.canadapharmacy.com they can cause. I was thinking about starting practicing yoga. What do you think? Is anybody here who tried it? I'll also think about a spine roller as it seems a good device that might help.

Most Important Articles That You Must Read. Hope You Will Love These Articles :: https://cutt.ly/3VQhbIi https://cutt.ly/JVQhvvQ https://cutt.ly/pVQhmJE https://cutt.ly/hVzeMo4 https://cutt.ly/iVzryST https://cutt.ly/qVzrpUn https://cutt.ly/NVzrswB https://cutt.ly/0Vzrdzt https://cutt.ly/AVzrf7O https://cutt.ly/MVzrhNl https://cutt.ly/1Vzrlnr https://cutt.ly/bVzrcqf https://cutt.ly/TVzrDmb https://cutt.ly/uVzrHcC https://cutt.ly/jVzrKXI https://cutt.ly/UVzrXRe https://cutt.ly/CVzrC1e https://cutt.ly/CVzrBzX https://cutt.ly/iVzrNQk https://cutt.ly/rVzrMHH https://cutt.ly/6Vzr18a https://cutt.ly/8Vzr2w9 https://cutt.ly/CVztt6U https://cutt.ly/CVztukJ https://cutt.ly/OVztoO9 https://cutt.ly/KVztp35 https://cutt.ly/yVztslS https://cutt.ly/4Vztd0s https://cutt.ly/jVztgWa https://cutt.ly/3VzthGR https://cutt.ly/8Vztj6r https://cutt.ly/uVztldr https://cutt.ly/2VztYFl https://cutt.ly/aVztItp https://cutt.ly/PVztINm https://cutt.ly/bVztPUR https://cutt.ly/4VztSw0 https://cutt.ly/MVztDMn https://cutt.ly/nVc9VKj https://cutt.ly/rVc9BEv https://cutt.ly/SVc9Nvs

Department of Health and Social Care (DHSC) has issued a medicine supply notification for GLP-1 receptor agonists used in the management of type 2 diabetes on Tuesday (27 June). "There are very limited, intermittent supplies of all glucagon-like peptide-1 receptor agonists (GLP-1 RAs) licensed in the management of Type 2 Diabetes Mellitus (T2DM)," said DHSC. The supply issues have been caused by an increase in demand for these products for licensed and off-label indications and it is not expected to return to normal until at least mid-2024. Pharmacists are urged to refer to the SPS Tool for Medicines Shortages for an up-to-date supply stock situation and clinical guidance on alternative treatment options.

The Medicines and Healthcare Products Regulatory Agency (MHRA) has authorised an innovative and first-of-its-kind gene-editing treatment for sickle-cell disease and transfusion-dependent β-thalassemia. Known as Casgevy (exagamglogene autotemcel), the treatment is based on the innovative gene-editing tool CRISPR, for which its inventors were awarded the Nobel Prize in 2020. Casgevy is the first medicine to be licensed that uses CRISPR, and it is to be used for treating patients aged 12 and over. To date, a bone marrow transplant has been the only permanent treatment option for these life-long conditions, which in some cases can be fatal. The MHRA's authorisation came after a rigorous assessment of its safety, quality and effectiveness.

Le coût de la thérapie par cellules souches en Inde, entre 5 lakhs et 8 lakhs, est un élément principal qui fournit une nouvelle lueur d'espoir aux patients du monde entier, car les services cliniques de première classe fournis par les hôpitaux sont à la hauteur.

The new Smoking Cessation Service (SCS) will commence on March 10, 2022, allowing community pharmacy contractors to register to provide the service on the NHS Business Services Authority's (NHSBSA) Manage Your Service (MYS) portal from March 1, 2022. This is the second of the two new Advanced services to be introduced this financial year, after the Hypertension case-finding service, which were agreed outcomes from negotiations for Year 3 of the Community Pharmacy Contractual Framework. Since the service is an Advanced service, contractors are free to decide if they wish to provide it, as most would be busy completing work for the Pharmacy Quality Scheme 2021/22 alongside winter-related workload, the Pharmaceutical Services Negotiating Committee said. Therefore, those who decide to start this service should consider the likelihood of receiving sufficient referrals to make provision of the service worthwhile, the PSNC said.

To bring new therapies to market, pharmaceutical, biotechnology, and medical device companies engage contract research organizations (CROs).

Psoriasis vs Eczema, while both causing itchy, inflamed skin, are distinct conditions with different underlying causes and treatments. Understanding these differences is crucial for proper diagnosis and management. Symptoms: Psoriasis: Thick, red, scaly patches: Often on elbows, knees, scalp, but can affect any area. Silvery scales: Easily removed, revealing inflamed skin beneath. Eczema: Dry, itchy, red patches: Often on inner elbows, knees, hands, face, but can be widespread. Fine, scaling: Less prominent compared to psoriasis. Causes: Psoriasis: Autoimmune condition: Immune system mistakenly attacks healthy skin cells, causing rapid growth and buildup. Genetic predisposition: Family history increases risk. Eczema: Atopic dermatitis: Combination of genetic and environmental factors. Dry skin: Major contributing factor. Treatments: Psoriasis: Topical medications: Steroids, retinoids, vitamin D analogues to reduce inflammation and cell growth. Light therapy: Ultraviolet light exposure to slow skin cell production. Eczema: Moisturizers: Regular use hydrates and protects the skin barrier. Emollients: Oil-based creams to soothe dryness and itching. Key Differences: Cause: Psoriasis is autoimmune, while eczema is complex and involves both genetics and environment. Symptoms: Psoriasis typically has thicker scales and less itching, while eczema is drier and itchier.